Relapsed or Refractory Mantle Cell Lymphoma (MCL) (1)

Completed (1)

phase 2 (1)

US Oncology Research (1)

Eli Lilly and Company (1)

gemcitabine (1)

mitoxantrone (1)

rituximab (1)

drug (1)

Industry (1)

Interventional (1)

relapsed or refractory mantle cell lymphoma (mcl)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Sep 15, 2016